276 related articles for article (PubMed ID: 12725870)
1. Organization of multiple cytochrome P450s with NADPH-cytochrome P450 reductase in membranes.
Backes WL; Kelley RW
Pharmacol Ther; 2003 May; 98(2):221-33. PubMed ID: 12725870
[TBL] [Abstract][Full Text] [Related]
2. One-electron reductive bioactivation of 2,3,5,6-tetramethylbenzoquinone by cytochrome P450.
Goeptar AR; te Koppele JM; van Maanen JM; Zoetemelk CE; Vermeulen NP
Biochem Pharmacol; 1992 Jan; 43(2):343-52. PubMed ID: 1310854
[TBL] [Abstract][Full Text] [Related]
3. P450BM-3; a tale of two domains--or is it three?
Peterson JA; Sevrioukova I; Truan G; Graham-Lorence SE
Steroids; 1997 Jan; 62(1):117-23. PubMed ID: 9029725
[TBL] [Abstract][Full Text] [Related]
4. Interactions of mammalian cytochrome P450, NADPH-cytochrome P450 reductase, and cytochrome b(5) enzymes.
Shimada T; Mernaugh RL; Guengerich FP
Arch Biochem Biophys; 2005 Mar; 435(1):207-16. PubMed ID: 15680923
[TBL] [Abstract][Full Text] [Related]
5. Roles of NADPH-P450 reductase and apo- and holo-cytochrome b5 on xenobiotic oxidations catalyzed by 12 recombinant human cytochrome P450s expressed in membranes of Escherichia coli.
Yamazaki H; Nakamura M; Komatsu T; Ohyama K; Hatanaka N; Asahi S; Shimada N; Guengerich FP; Shimada T; Nakajima M; Yokoi T
Protein Expr Purif; 2002 Apr; 24(3):329-37. PubMed ID: 11922748
[TBL] [Abstract][Full Text] [Related]
6. Human enzymes involved in the metabolic activation of the environmental contaminant 3-nitrobenzanthrone: evidence for reductive activation by human NADPH:cytochrome p450 reductase.
Arlt VM; Stiborova M; Hewer A; Schmeiser HH; Phillips DH
Cancer Res; 2003 Jun; 63(11):2752-61. PubMed ID: 12782579
[TBL] [Abstract][Full Text] [Related]
7. Kinetics of ferric cytochrome P450 reduction by NADPH-cytochrome P450 reductase: rapid reduction in the absence of substrate and variations among cytochrome P450 systems.
Guengerich FP; Johnson WW
Biochemistry; 1997 Dec; 36(48):14741-50. PubMed ID: 9398194
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of monomeric reconstituted and membrane microsomal monooxygenase systems of the rabbit liver. II. Kinetic parameters of reductase and monooxygenase reactions.
Kanaeva IP; Nikityuk OV; Davydov DR; Dedinskii IR; Koen YM; Kuznetsova GP; Skotselyas ED; Bachmanova GI; Archakov AI
Arch Biochem Biophys; 1992 Nov; 298(2):403-12. PubMed ID: 1416971
[TBL] [Abstract][Full Text] [Related]
9. Dynamic interactions of rabbit liver cytochromes P450IA2 and P450IIB4 with cytochrome b5 and NADPH-cytochrome P450 reductase in proteoliposomes.
Yamada M; Ohta Y; Bachmanova GI; Nishimoto Y; Archakov AI; Kawato S
Biochemistry; 1995 Aug; 34(32):10113-9. PubMed ID: 7640265
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of monomeric reconstituted and membrane microsomal monooxygenase systems of the rabbit liver. I. Properties of NADPH-cytochrome P450 reductase and cytochrome P450 LM2 (2B4) monomers.
Kanaeva IP; Dedinskii IR; Skotselyas ED; Krainev AG; Guleva IV; Sevryukova IF; Koen YM; Kuznetsova GP; Bachmanova GI; Archakov AI
Arch Biochem Biophys; 1992 Nov; 298(2):395-402. PubMed ID: 1416970
[TBL] [Abstract][Full Text] [Related]
11. Cytochrome P450 Organization and Function Are Modulated by Endoplasmic Reticulum Phospholipid Heterogeneity.
Brignac-Huber LM; Park JW; Reed JR; Backes WL
Drug Metab Dispos; 2016 Dec; 44(12):1859-1866. PubMed ID: 27233287
[TBL] [Abstract][Full Text] [Related]
12. A large-scale comparative analysis of affinity, thermodynamics and functional characteristics of interactions of twelve cytochrome P450 isoforms and their redox partners.
Yablokov EO; Sushko TA; Ershov PV; Florinskaya AV; Gnedenko OV; Shkel TV; Grabovec IP; Strushkevich NV; Kaluzhskiy LA; Usanov SA; Gilep AA; Ivanov AS
Biochimie; 2019 Jul; 162():156-166. PubMed ID: 31034920
[TBL] [Abstract][Full Text] [Related]
13. Requirements for cytochrome b5 in the oxidation of 7-ethoxycoumarin, chlorzoxazone, aniline, and N-nitrosodimethylamine by recombinant cytochrome P450 2E1 and by human liver microsomes.
Yamazaki H; Nakano M; Gillam EM; Bell LC; Guengerich FP; Shimada T
Biochem Pharmacol; 1996 Jul; 52(2):301-9. PubMed ID: 8694855
[TBL] [Abstract][Full Text] [Related]
14. NADPH-flavodoxin reductase and flavodoxin from Escherichia coli: characteristics as a soluble microsomal P450 reductase.
Jenkins CM; Waterman MR
Biochemistry; 1998 Apr; 37(17):6106-13. PubMed ID: 9558349
[TBL] [Abstract][Full Text] [Related]
15. Formation of P450 · P450 complexes and their effect on P450 function.
Reed JR; Backes WL
Pharmacol Ther; 2012 Mar; 133(3):299-310. PubMed ID: 22155419
[TBL] [Abstract][Full Text] [Related]
16. Differential effect of copper (II) on the cytochrome P450 enzymes and NADPH-cytochrome P450 reductase: inhibition of cytochrome P450-catalyzed reactions by copper (II) ion.
Kim JS; Ahn T; Yim SK; Yun CH
Biochemistry; 2002 Jul; 41(30):9438-47. PubMed ID: 12135366
[TBL] [Abstract][Full Text] [Related]
17. Fluorescence resonance energy transfer analysis of cytochromes P450 2C2 and 2E1 molecular interactions in living cells.
Szczesna-Skorupa E; Mallah B; Kemper B
J Biol Chem; 2003 Aug; 278(33):31269-76. PubMed ID: 12766165
[TBL] [Abstract][Full Text] [Related]
18. The use of liposomes in the study of drug metabolism: a method to incorporate the enzymes of the cytochrome p450 monooxygenase system into phospholipid, bilayer vesicles.
Reed JR
Methods Mol Biol; 2010; 606():11-20. PubMed ID: 20013386
[TBL] [Abstract][Full Text] [Related]
19. Microsomal cytochrome P450 2C5: comparison to microbial P450s and unique features.
Williams PA; Cosme J; Sridhar V; Johnson EF; McRee DE
J Inorg Biochem; 2000 Aug; 81(3):183-90. PubMed ID: 11051563
[TBL] [Abstract][Full Text] [Related]
20. Microsomal cytochrome P450 1A1 dependent monooxygenase activity in guinea pig heart: induction, inhibition, and increased activity by addition of exogenous NADPH-cytochrome P450 reductase.
McCallum GP; Horton JE; Falkner KC; Bend JR
Can J Physiol Pharmacol; 1993 Feb; 71(2):151-6. PubMed ID: 8319138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
